Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Krishnan

Showing results (261-270 of 337) with videos related to

Pageof 34
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapyValerie K Reed, Sunil Krishnan, Paul F Mansfield, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Frontiers in Cardiovascular Medicine|March 30, 2018
Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 PhosphorylationHang Thi Vu, Sivareddy Kotla, Kyung Ae Ko, et al.
American Journal of Clinical Oncology|October 19, 2016
Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive ChemoradiationEleanor M Osborne, Cathy Eng, John M Skibber, et al.
Clinical Colorectal Cancer|March 17, 2020
Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal AdenocarcinomaSantiago Avila, George J Chang, N Arvind Dasari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinomaEmma B Holliday, Andrew Hunt, Y Nancy You, et al.
Rare Tumors|October 3, 2014
The rare cancer network: ongoing studies and future strategyMahmut Ozsahin, René-Olivier Mirimanoff, Juliette Thariat, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das, Edward H Lin, Sumita Bhatia, et al.
Pageof 34

Showing results (261-270 of 337) with videos related to

Sort By:
Pageof 34
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapyValerie K Reed, Sunil Krishnan, Paul F Mansfield, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Frontiers in Cardiovascular Medicine|March 30, 2018
Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 PhosphorylationHang Thi Vu, Sivareddy Kotla, Kyung Ae Ko, et al.
American Journal of Clinical Oncology|October 19, 2016
Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive ChemoradiationEleanor M Osborne, Cathy Eng, John M Skibber, et al.
Clinical Colorectal Cancer|March 17, 2020
Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal AdenocarcinomaSantiago Avila, George J Chang, N Arvind Dasari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinomaEmma B Holliday, Andrew Hunt, Y Nancy You, et al.
Rare Tumors|October 3, 2014
The rare cancer network: ongoing studies and future strategyMahmut Ozsahin, René-Olivier Mirimanoff, Juliette Thariat, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das, Edward H Lin, Sumita Bhatia, et al.
Pageof 34